Cumberland Pharmaceuticals Inc. (CPIX)
Trading performance
- Closing price on Tuesday, 20 Oct 2026: USD 7.80 per share.
- 24‑hour change: –6.69 %.
- 24‑hour trading volume: USD 603 k.
- Shares outstanding: 15 million.
- Market capitalization: USD 107.6 million.
Historical context
- Price change since the end of the previous month: –11.73 %.
- 200‑day simple moving average: USD 5.45.
- 52‑week high: USD 9.28 (26 Aug 2026).
- 52‑week low: USD 1.85 (18 Nov 2025).
Upcoming corporate event Cumberland Pharmaceuticals Inc. will host a national webcast and conference call on 26 Oct 2026 at 4:30 p.m. Eastern Time. The session will provide a progress update on the company’s ifetroban candidate, a therapeutic being investigated for cardiomyopathy associated with Duchenne muscular dystrophy. Participants can view slides via webcast or join the audio‑only call. After the event, a copy of the presentation will be posted on the Investor Relations page of the company’s website.
Industry focus The company develops therapies for Duchenne muscular dystrophy, systemic sclerosis, idiopathic pulmonary fibrosis, and cancer metastasis. Its product pipeline targets critical care, emergency medicine, and gastroenterology markets.
Peer comparison (24‑hour performance)
| Symbol | 24‑hour change | Current price | Market cap (USD mn) |
|---|---|---|---|
| NEOV | –1.37 % | USD 2.13 | USD 127.2 |
| CURN | 0 % | USD 21.66 | USD 128.8 |
| NKTX | –2.78 % | USD 1.79 | USD 128.9 |
| ORGO | +2 % | USD 1.04 | USD 128.6 |
| ANTX | –0.3 % | USD 3.56 | USD 127.6 |
Corporate details Cumberland Pharmaceuticals Inc. is headquartered in Nashville, Tennessee, USA. The company was listed on the Nasdaq exchange in August 2009. Further information is available on its website: www.cumberlandpharma.com .
